MARC Record from marc_columbia

LEADER: 05288cam a2200781 i 4500
001 12871861
005 20220611224256.0
006 m o d
007 cr cn|||||||||
008 080220s2001 mdu ob 001 0 eng d
035 $a(OCoLC)ocn192134876
035 $a(NNC)12871861
040 $aBUF$beng$erda$epn$cBUF$dKNOVL$dOCLCQ$dOCLCO$dKNOVL$dZCU$dKNOVL$dOCLCQ$dCOCUF$dN$T$dYDXCP$dDKDLA$dCCO$dE7B$dCN5CF$dOCLCQ$dEBLCP$dOCLCQ$dUAB$dOCLCQ$dOCLCO$dOCLCA$dBUF$dOCLCO$dCEF$dOCL$dWYU$dOCLCQ$dHNC$dOCLCO$dOCLCQ
019 $a173282493$a290554844$a475475462$a568141851$a646752590$a755664952$a923311426
020 $a0929600681$q(print)
020 $a9780929600680$q(print)
020 $a9781601193940$q(electronic book)
020 $a1601193947$q(electronic book)
020 $a9781429498890$q(electronic bk.)
020 $a1429498897$q(electronic bk.)
035 $a(OCoLC)192134876$z(OCoLC)173282493$z(OCoLC)290554844$z(OCoLC)475475462$z(OCoLC)568141851$z(OCoLC)646752590$z(OCoLC)755664952$z(OCoLC)923311426
050 4 $aRC280.L5$bN37 2001eb
060 4 $aWI 735$bN277L 2001
072 7 $aMED$x062000$2bisacsh
072 7 $aHEA$x039030$2bisacsh
082 04 $a616.99/436071$222
049 $aZCUA
110 2 $aNational Council on Radiation Protection and Measurements.
245 10 $aLiver cancer risk from internally-deposited radionuclides :$brecommendation of the National Council on Radiation Protection and Measurements.
264 1 $aBethesda, Maryland :$bThe Council,$c2001.
300 $a1 online resource
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aNCRP report ;$vno. 135
500 $a"Issued March 9, 2001."
504 $aIncludes bibliographical references (pages 56-73) and index.
588 0 $aPrint version record.
505 0 $aCover Page -- Preface -- Contents -- 1. Overview -- 2. Affinity of Radionuclides for Liver Tissue -- 2.1 Characteristics of Liver Tissue -- 2.2 Affinity of Radionuclides in Ionic or Compound Forms in Various Tissues -- 2.3 Distribution of Radionuclides in Colloidal or Particulate Form -- 3. Effective Half-Life -- 4. Radiation Dose from Internally-Deposited Radionuclides -- 5. Radiosensitivity of Liver Tissue -- 5.1 Sensitivity to Morphological Changes -- 5.2 Sensitivity for Cell Killing -- 5.3 Influence of Latent Period on Cancer Risk
505 8 $a""5.4 Sensitivity for Cancer Induction""""6. Physical Variables that Alter Response""; ""6.1 Cellular and Tissue Dose Distribution""; ""6.1.1 Influence of Dose Distribution at the Cellular Level""; ""6.1.2 Influence of Dose Distribution on Liver Cancer""; ""6.2 Influence of “Particle Loading� on Cancer Induction""; ""6.3 The Role of Injury on Cancer""; ""6.4 The Role of Mechanistic Studies on Liver Cancer Risks""; ""7. Use of Experimental Animal Data""; ""7.1 Relative Biological Effectiveness of the Radiation Emitted by Radionuclides""; ""7.2 Liver Cancer Risk from Animal Data""
505 8 $a""8. Liver Risk Estimates in Humans""""9. Uncertainty in Current Risk Estimates""; ""9.1 Strengths of the Data""; ""9.1.1 Identification of the Thorotrast® Population""; ""9.1.2 Defined Dose and Response Relationships""; ""9.1.3 Transfer of the Information to other Populations""; ""9.2 Weaknesses of the Data""; ""9.2.1 Dose Range and Dose Used in Risk Estimates""; ""9.2.2 Uncertainty Related to “Wasted Dose� Estimates""; ""9.2.3 Uncertainty Associated with Dose Distribution""; ""9.2.4 Uncertainty Associated with Extrapolations from Animal Data""
505 8 $a9.2.5 Uncertainty Related to Environmental Insults10. Summary -- References -- The NCRP -- Officers -- Members -- Honorary Members -- NCRP Publications -- NCRP Reports -- NCRP Commentaries -- Proceedings of the Annual Meeting -- Lauriston S. Taylor Lectures -- Symposium Proceedings -- NCRP Statements -- Other Documents -- Index
650 0 $aLiver$xCancer.
650 0 $aRadiographic contrast media$xCarcinogenicity.
650 0 $aRadiation carcinogenesis.
650 0 $aRadiation$xDosage.
650 0 $aRisk assessment.
650 12 $aLiver Neoplasms$xetiology
650 2 $aLiver Neoplasms
650 2 $aNeoplasms, Radiation-Induced
650 22 $aRadiation Dosage
650 22 $aRadioisotopes$xadverse effects
650 22 $aRisk Assessment
650 6 $aFoie$xCancer.
650 6 $aProduits de contraste$xCancérogénicité.
650 6 $aTumeurs dues aux radiations.
650 6 $aRayonnement$xDose.
650 6 $aÉvaluation du risque.
650 7 $arisk assessment.$2aat
650 7 $aMEDICAL$xOncology.$2bisacsh
650 7 $aHEALTH & FITNESS$xDiseases$xCancer.$2bisacsh
650 7 $aRadiation carcinogenesis.$2fast$0(OCoLC)fst01086911
650 7 $aLiver$xCancer.$2fast$0(OCoLC)fst01000624
655 4 $aElectronic books.
776 08 $iPrint version:$aNational Council on Radiation Protection and Measurements.$tLiver cancer risk from internally-deposited radionuclides.$dBethesda, Md. : The Council, 2001$z0929600681$w(OCoLC)45320947
830 0 $aNCRP report ;$vno. 135.
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio12871861$zACADEMIC - Safety & Industrial Hygiene
852 8 $blweb$hEBOOKS